CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended		79 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (1,767,192)	$ (646,109)	$ (7,616,098)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	25,488	24,375	193,686
Allowance for uncollectible notes receivable			38,867
Amortization of debt discount	106,358		108,578
Amortization of deferred finance costs		45,127	59,605
Interest (income) expense on fair value adjustment on convertible notes payable	(23,556)	50,278	426,797
Interest accrued on note receivable			(11,705)
Write-off of uncollectible deposit			20,000
Loss on extinguishment of debt		31,398	266,285
Loss on impairment			42,800
Stock issued for services	1,024,491	89,386	2,858,347
Stock issued to satisfy legal services	56,928		122,422
Stock issued for financing fees			5,000
Changes in operating assets and liabilities:
Prepaid expenses	13,559		(34,701)
Advances to shareholders	(2,500)	(1,016)	(3,516)
Deposits and other receivables			(23,345)
Accounts payable and accrued liabilities	86,162	20,243	318,363
Net cash used in operating activities	(480,262)	(386,318)	(3,113,787)
CASH FLOWS FROM INVESTING ACTIVITIES
Issuance of notes receivable			(25,000)
Purchase of investment in common stock		(12,000)	(34,100)
Acquisition of equipment			(325,000)
Net cash used in investing activities		(12,000)	(384,100)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the issuance of common stock	241,343	249,000	2,288,887
Proceeds from the issuance of convertible notes, related parties	55,500	50,000	111,500
Proceeds from the issuance of convertible notes, non related parties	169,500	95,480	704,000
Proceeds from the issuance of notes payable		10,000	286,500
Proceeds from the issuance of notes payable - related parties			8,500
Payments on convertible notes payable	(30,000)	(5,000)	(76,000)
Payments on notes payable		(10,000)	(57,500)
Payments on notes payable - related parties			(1,000)
Proceeds from loans from stockholders	7,500	5,000	48,425
Payments on loans from stockholders	(7,500)	(5,000)	(43,725)
Net cash provided by financing activities	436,343	389,480	3,497,887
NET DECREASE IN CASH	(43,919)	(8,838)
CASH, BEGINNING OF PERIOD	43,919	8,838
CASH, END OF PERIOD
NONCASH FINANCING ACTIVITIES:
Due to Organetix, Inc. reclassified to additional paid-in capital			91,500
Common stock issued in conjunction with a joint venture		9,800	9,800
Common stock issued to satisfy debt		266,690	76,528
Common stock issued to satisfy minimum value guarantee			87,667
Convertible debt converted to common stock including accrued interest	143,936	208,500	1,382,114
Common stock issued in exchange for a fixed asset			7,420
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest			$ 3,660